Your browser doesn't support javascript.
SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.
Appa, Ayesha; Chamie, Gabriel; Sawyer, Aenor; Baltzell, Kimberly; Dippell, Kathryn; Ribeiro, Salu; Duarte, Elias; Vinden, Joanna; Consortium, Cliahub; Kramer-Feldman, Jonathan; Rahdari, Shahryar; MacIntosh, Doug; Nicholson, Katherine; Im, Jonathan; Havlir, Diane; Greenhouse, Bryan.
  • Appa A; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA. Ayesha.appa@ucsf.edu.
  • Chamie G; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Sawyer A; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Baltzell K; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Dippell K; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Ribeiro S; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Duarte E; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Vinden J; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Consortium C; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Kramer-Feldman J; Chan Zuckerberg Biohub, San Francisco, USA.
  • Rahdari S; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • MacIntosh D; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Nicholson K; San Francisco State University, San Francisco, USA.
  • Im J; San Francisco State University, San Francisco, USA.
  • Havlir D; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
  • Greenhouse B; University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA.
Arch Public Health ; 79(1): 125, 2021 Jul 07.
Article in English | MEDLINE | ID: covidwho-1496223
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community.

METHODS:

A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days (April 20th - April 23rd, 2020). Prior to testing, key preparatory elements included community mobilization, pre-registration, volunteer recruitment, and data management. On day of testing, participants were directed to a testing lane after site entry. An administrator viewed the lane-specific queue and pre-prepared test kits, linked to participants' records. Medical personnel performed sample collection, which included finger prick with blood collection to run laboratory-based antibody testing and respiratory specimen collection for polymerase chain reaction (PCR).

RESULTS:

Using this 4-lane model, 1,840 participants were tested in 4 days. A median of 57 participants (IQR 47-67) were tested hourly. The fewest participants were tested on day 1 (n = 338 participants), an intentionally lower volume day, increasing to n = 571 participants on day 4. The number of testing teams was also increased to two per lane to allow simultaneous testing of multiple participants on days 2-4. Consistent staffing on all days helped optimize proficiency, and strong community partnership was essential from planning through execution.

CONCLUSIONS:

High-volume ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was feasible when conducted in a community-led, drive-through model in a non-urban area.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: Arch Public Health Year: 2021 Document Type: Article Affiliation country: S13690-021-00647-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: Arch Public Health Year: 2021 Document Type: Article Affiliation country: S13690-021-00647-8